generic_name,dosage_form,strength,therapeutic_category,who_list_section,notes,unit,reorder_level
lidocaine + epinephrine (adrenaline),Injection,1%,WHO EML 2023,Core,"1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES",vial,20
lidocaine + epinephrine (adrenaline),Injection,2% (hydrochloride or sulfate) + epinephrine,WHO EML 2023,Core,"1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES",vial,20
lidocaine + epinephrine (adrenaline),Injection,30 mg/mL (hydrochloride) in 1 mL ampoule,WHO EML 2023,Complementary,"1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES",vial,20
ephedrine,Injection,1 mg (sulfate) in 1 mL ampoule,WHO EML 2023,Complementary,"1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES",vial,20
ephedrine,Injection,1 mg/mL,WHO EML 2023,Complementary,"1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES",vial,20
ephedrine,Oral liquid,2 mg/mL,WHO EML 2023,Complementary,"1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES",bottle,20
ephedrine,Tablet,7.5 mg,WHO EML 2023,Complementary,"1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES",strip,20
ephedrine,Tablet,15 mg,WHO EML 2023,Complementary,"1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES",strip,20
ephedrine,Injection,10 mg (sulfate or hydrochloride) in 1 mL ampoule,WHO EML 2023,Complementary,"1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES",vial,20
ephedrine,Suppository,50 mg to 150 mg,WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
acetylsalicylic acid,Tablet,100 mg to 500 mg,WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Oral liquid,"100 mg/5 mL , 200 mg/5 mL",WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,bottle,20
acetylsalicylic acid,Tablet,200 mg,WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Tablet,400 mg,WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Tablet,600 mg,WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Oral liquid,"120 mg/5 mL or 125 mg/5 mL**, 250 mg/5 mL",WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,bottle,20
acetylsalicylic acid,Suppository,"100 mg, 250 mg",WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
acetylsalicylic acid,Tablet,"250 mg, 325 mg, 500 mg",WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Tablet,"100 mg, 250 mg",WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Tablet,30 mg (phosphate),WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Transdermal patch,12 micrograms/hr,WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
acetylsalicylic acid,Transdermal patch,25 micrograms/hr,WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
acetylsalicylic acid,Granules,20 mg to 200 mg,WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,packet,20
acetylsalicylic acid,Injection,10 mg (morphine hydrochloride or morphine sulfate) in,WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,vial,20
acetylsalicylic acid,Therapeutic,Oral liquid: 10 mg/5 mL (morphine hydrochloride or morphine,WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
acetylsalicylic acid,Tablet,10 mg to 200mg (morphine hydrochloride or,WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Tablet,10 mg (morphine sulfate),WHO EML 2023,Core,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Tablet,5 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Tablet,10 mg (hydrochloride),WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Oral liquid,5 mg/5 mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,bottle,20
acetylsalicylic acid,Oral liquid,10 mg/5 mL (hydrochloride),WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,bottle,20
acetylsalicylic acid,Concentrate,5 mg/mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
acetylsalicylic acid,Concentrate,10 mg/mL (hydrochloride),WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
acetylsalicylic acid,Tablet,10 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Tablet,25 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Tablet,75 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Injection,50 mg/mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,vial,20
acetylsalicylic acid,Tablet,50 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Injection,4 mg/mL (as disodium phosphate salt) in 1 mL ampoule,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,vial,20
acetylsalicylic acid,Oral liquid,2 mg/5 mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,bottle,20
acetylsalicylic acid,Tablet,2 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Tablet,4 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
acetylsalicylic acid,Injection,5 mg/mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,vial,20
acetylsalicylic acid,Rectal gel,"5 mg/mL in 0.5 mL, 2 mL, 4 mL rectal delivery system",WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
diazepam,Rectal solution,"2 mg/mL in 1.25 mL, 2.5 mL rectal tube",WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
diazepam,Rectal solution,4 mg/mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
diazepam,Tablet,5 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
diazepam,Tablet,10 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
diazepam,Capsule,100 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,strip,20
docusate sodium,Oral liquid,50 mg/5 mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,bottle,20
docusate sodium,fluoxetine,20 mg (as hydrochloride),WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
docusate sodium,Injection,5 mg in 1 mL ampoule,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,vial,20
docusate sodium,Oral liquid,2 mg/mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,bottle,20
docusate sodium,Solid,0.5 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
docusate sodium,Solid,2mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
docusate sodium,Solid,5 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
docusate sodium,Injection,20 mg/mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,vial,20
docusate sodium,Injection,400 micrograms/mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,vial,20
docusate sodium,Injection,600 micrograms/mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,vial,20
docusate sodium,Transdermal patch,1 mg/72 hours,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
docusate sodium,Oral liquid,3.1 to 3.7 g/5 mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,bottle,20
docusate sodium,loperamide,2 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
docusate sodium,Injection,5 mg/mL (hydrochloride) in 2 mL ampoule,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,vial,20
docusate sodium,Oral liquid,5 mg/5 mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,bottle,20
docusate sodium,Solid,10 mg (hydrochloride),WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
docusate sodium,Injection,1 mg/mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,vial,20
docusate sodium,Injection,5 mg/mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,vial,20
docusate sodium,Oral liquid,2mg/mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,bottle,20
docusate sodium,Solid,7.5 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
docusate sodium,Solid,15 mg,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
docusate sodium,Therapeutic,Oral liquid: 4 mg base/5 mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
docusate sodium,Solid,4 mg base,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
docusate sodium,Solid,8 mg base,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,unit,20
docusate sodium,Oral liquid,7.5 mg/5 mL,WHO EML 2023,Complementary,2. MEDICINES FOR PAIN AND PALLIATIVE CARE,bottle,20
docusate sodium,Injection,4 mg/mL (as disodium phosphate salt) in 1 mL ampoule,WHO EML 2023,Core,3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS,vial,20
docusate sodium,Injection,1 mg/mL (as hydrochloride or hydrogen tartrate) in 1 mL,WHO EML 2023,Core,3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS,vial,20
epinephrine (adrenaline),hydrocortisone,100 mg (as sodium succinate) in vial,WHO EML 2023,Core,3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS,unit,20
epinephrine (adrenaline),Therapeutic,Tablet: 10 mg,WHO EML 2023,Core,3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS,unit,20
epinephrine (adrenaline),Oral liquid,5 mg/mL,WHO EML 2023,Core,3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS,bottle,20
epinephrine (adrenaline),Tablet,5 mg,WHO EML 2023,Core,3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS,strip,20
epinephrine (adrenaline),Tablet,25 mg,WHO EML 2023,Core,3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS,strip,20
epinephrine (adrenaline),Injection,200 mg/mL in 10 mL ampoule,WHO EML 2023,Core,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,vial,20
acetylcysteine,Oral liquid,10%,WHO EML 2023,Core,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,bottle,20
acetylcysteine,Oral liquid,20%,WHO EML 2023,Core,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,bottle,20
acetylcysteine,Injection,1 mg (sulfate) in 1 mL ampoule,WHO EML 2023,Core,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,vial,20
acetylcysteine,Injection,100 mg/mL in 10 mL ampoule,WHO EML 2023,Core,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,vial,20
methylthioninium chloride,Injection,10 mg/mL in 10 mL ampoule,WHO EML 2023,Core,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,vial,20
methylthioninium chloride,Injection,400 micrograms (hydrochloride) in 1 mL ampoule,WHO EML 2023,Core,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,vial,20
methylthioninium chloride,penicillamine,250 mg,WHO EML 2023,Core,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,unit,20
methylthioninium chloride,Injection,30 mg/mL in 10 mL ampoule,WHO EML 2023,Core,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,vial,20
methylthioninium chloride,Injection,250 mg/mL in 50 mL ampoule,WHO EML 2023,Core,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,vial,20
methylthioninium chloride,deferoxamine,500 mg (mesilate) in vial,WHO EML 2023,Complementary,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,unit,20
methylthioninium chloride,dimercaprol,50 mg/mL in 2 mL ampoule,WHO EML 2023,Complementary,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,unit,20
methylthioninium chloride,Injection,5 mg/mL (sulfate) in 20 mL ampoule or 1 g/mL (base) in,WHO EML 2023,Complementary,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,vial,20
fomepizole,Injection,200 mg/mL in 5 mL ampoule,WHO EML 2023,Complementary,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,vial,20
fomepizole,succimer,100 mg,WHO EML 2023,Complementary,4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS,unit,20
fomepizole,Oral liquid,100 mg/5 mL,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,bottle,20
fomepizole,carbamazepine,100 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
fomepizole,carbamazepine,200 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
fomepizole,Tablet,100 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
fomepizole,Tablet,200 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
fomepizole,Tablet,400 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
fomepizole,Rectal gel,"5 mg/mL in 0.5 mL, 2 mL, 4 mL rectal delivery system",WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
diazepam,Rectal solution,"2 mg/mL in 1.25 mL, 2.5 mL rectal tube",WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
diazepam,Rectal solution,4 mg/mL,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
diazepam,Tablet,25 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
diazepam,Tablet,50 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
diazepam,Tablet,100 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
diazepam,Tablet,200 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
diazepam,Tablet,2 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
diazepam,Tablet,5 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
diazepam,Oral solution,100 mg/mL,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,bottle,20
levetiracetam,Tablet,250 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
levetiracetam,Tablet,500 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
levetiracetam,Tablet,750 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
levetiracetam,Tablet,1000 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
levetiracetam,Injection,2 mg/mL in 1 mL ampoule,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
levetiracetam,Injection,4 mg/mL in 1 mL ampoule,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
levetiracetam,Injection,0.5 g/mL in 2 mL ampoule (equivalent to 1 g in 2 mL,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
levetiracetam,Solution,"5 mg/mL in 0.5 mL, 1 mL,",WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
levetiracetam,midazolam,1 mg/mL in 5 mL vial,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
levetiracetam,midazolam,5 mg/mL in 1 mL or 3 mL vial,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
levetiracetam,Injection,"30 mg/mL or 60 mg/mL , 200 mg/mL (sodium)",WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
levetiracetam,Oral liquid,15 mg/5 mL,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,bottle,20
levetiracetam,Tablet,15 mg to 100 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
levetiracetam,Injection,50 mg/mL (phenytoin sodium),WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
levetiracetam,Oral liquid,30 mg/5 mL (phenytoin),WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,bottle,20
phenytoin,Solid,25 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
phenytoin,Solid,50 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
phenytoin,Solid,100 mg (phenytoin sodium),WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
phenytoin,Tablet,50 mg (phenytoin),WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
phenytoin,Oral liquid,200 mg/5 mL,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,bottle,20
phenytoin,child-bearing,100 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
are ineffective or not tolerated because of the high risk,of,200 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
are ineffective or not tolerated because of the high risk,of,500 mg,WHO EML 2023,Core,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
are ineffective or not tolerated because of the high risk,Capsule,250 mg,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
ethosuximide,Oral liquid,250 mg/5 mL,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,bottle,20
ethosuximide,Concentrate solution for infusion,500 mg/5mL in 5 mL vial,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
levetiracetam,Solution for infusion,5 mg/mL,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
levetiracetam,Solution for infusion,10 mg/mL,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
levetiracetam,Solution for infusion,15 mg/mL in 100 mL,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
levetiracetam,Injection,"100 mg/mL in 3 mL, 4 mL, 10 mL ampoule",WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
defects and developmental disorders in,Tablet,10 mg,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
defects and developmental disorders in,Injection,20 mg/mL,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
defects and developmental disorders in,Injection,40 mg/mL in pre-filled,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
glatiramer acetate,Injection,500 mg/50 mL in 50 mL vial,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
glatiramer acetate,Injection,5 mg (lactate) in 1 mL ampoule,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,vial,20
glatiramer acetate,Tablet,2 mg (hydrochloride),WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,strip,20
glatiramer acetate,Therapeutic,Tablet: 100 mg + 10 mg,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
glatiramer acetate,Therapeutic,100 mg + 25 mg,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
glatiramer acetate,Therapeutic,250 mg + 25 mg,WHO EML 2023,Complementary,5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM,unit,20
glatiramer acetate,albendazole,400 mg,WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,unit,20
glatiramer acetate,Tablet,3 mg,WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,strip,20
glatiramer acetate,Tablet,50 mg,WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,strip,20
glatiramer acetate,Tablet,150 mg (as hydrochloride),WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,strip,20
glatiramer acetate,mebendazole,100 mg,WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,unit,20
glatiramer acetate,mebendazole,500 mg,WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,unit,20
glatiramer acetate,niclosamide,500 mg,WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,unit,20
glatiramer acetate,Tablet,"150 mg, 500 mg",WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,strip,20
praziquantel,Tablet,600 mg,WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,strip,20
praziquantel,pyrantel,250 mg (as embonate or pamoate),WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,unit,20
praziquantel,albendazole,400 mg,WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,unit,20
praziquantel,Tablet,50 mg,WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,strip,20
praziquantel,Tablet,100 mg (dihydrogen citrate),WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,strip,20
praziquantel,Tablet,3 mg,WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,strip,20
praziquantel,Tablet,"150 mg, 500 mg",WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,strip,20
praziquantel,triclabendazole,250 mg,WHO EML 2023,Core,6. ANTI-INFECTIVE MEDICINES,unit,20
praziquantel,Capsule,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
praziquantel,Oral liquid,250 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
praziquantel,Tablet,200 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
albendazole,Tablet,400 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
albendazole,mebendazole,"100 mg , 500 mg",WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,25
albendazole,Tablet,"150 mg, 500 mg",WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
praziquantel,Tablet,600 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
praziquantel,Injection,50 mg/mL (as sulfate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
praziquantel,Injection,250 mg/mL (as sulfate) in 2 mL vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
amikacin,Powder for injection,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
amikacin,Powder for injection,500 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
amikacin,Powder for injection,1 g (as sodium) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
amikacin,Powder for oral liquid,125 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
amikacin,Powder for oral liquid,250 mg/5 mL (as trihydrate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
amikacin,Solid,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
amikacin,Solid,500 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
amikacin,Solid,1g (as trihydrate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
amikacin,Tablet,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
amikacin,Tablet,500 mg (as trihydrate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
amikacin,Powder for injection,500 mg (as sodium) + 100 mg (as potassium salt),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
amikacin,Powder for injection,1000 mg (as,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
amikacin,Powder for oral liquid,125 mg (as trihydrate)+ 31.25 mg (as potassium salt)/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
amikacin,Tablet,500 mg (as trihydrate) + 125 mg (as potassium salt),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
amikacin,Tablet,875 mg (as trihydrate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
amikacin,Tablet,200 mg (as trihydrate) + 28.5 mg (as potassium salt),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
infections (mild to moderate),Powder for injection,500 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
infections (mild to moderate),Powder for injection,1 g (as sodium) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
ampicillin,Powder for injection,1.2 million IU (≈ 900 mg) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
ampicillin,Powder for injection,2.4 million IU (≈ 1.8 g) in,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
benzathine benzylpenicillin,Powder for injection,600 mg (= 1 million IU),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
benzathine benzylpenicillin,Powder for injection,3 g (= 5 million IU) (sodium or,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
benzathine benzylpenicillin,Powder for oral liquid,125 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,25
benzathine benzylpenicillin,Powder for oral liquid,250 mg/5 mL (anhydrous),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,25
benzathine benzylpenicillin,Solid,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,25
benzathine benzylpenicillin,Solid,500 mg (as monohydrate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,25
benzathine benzylpenicillin,Tablet,125 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
benzathine benzylpenicillin,Tablet,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
cefalexin,Powder for injection,1 g (as sodium salt) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
cefazolin a,Oily suspension for injection,0.5 g/mL (as sodium succinate) in 2 mL ampoule,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
cefazolin a,chloramphenicol,1 g (as sodium succinate) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,25
cefazolin a,Capsule,150 mg (as hydrochloride),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
cefazolin a,Injection,150 mg/mL (as phosphate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
cefazolin a,Injection,600 mg/4 mL (as phosphate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
cefazolin a,Injection,900 mg/6 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
clindamycin,Powder for oral liquid,75 mg/5 mL (as palmitate hydrochloride),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
clindamycin,Capsule,"250 mg , 500 mg",WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
clindamycin,Capsule,1 g (as sodium),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
clindamycin,Powder for injection,"250 mg , 500 mg (as sodium) in vial",WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
clindamycin,Powder for oral liquid,"125 mg/5 mL, 250 mg/5 mL (as sodium)",WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
penicillins),Oral liquid,50 mg/5 mL (calcium),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,25
penicillins),Powder for oral liquid,25 mg/5 mL (monohydrate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,25
penicillins),Powder for injection,100 mg in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
penicillins),Solid,50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,25
penicillins),Solid,100 mg (as hyclate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,25
penicillins),Tablet,100 mg (as monohydrate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
doxycycline a,Injection,10 mg/mL (as sulfate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
doxycycline a,Injection,40 mg/mL (as sulfate) in 2 mL vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
gentamicin,Injection,500 mg in 100 mL vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
gentamicin,Oral liquid,200 mg/5 mL (as benzoate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
gentamicin,Suppository,500 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
gentamicin,Suppository,1 g,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
gentamicin,Tablet,200 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
gentamicin,Tablet,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
gentamicin,Tablet,400 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
gentamicin,Tablet,500 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
infections (severe),Oral liquid,25 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
infections (severe),Solid,50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
infections (severe),Solid,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
nitrofurantoin,Powder for oral liquid,250 mg/5 mL (as potassium),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
nitrofurantoin,Solid,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
nitrofurantoin,Solid,500 mg (as potassium),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
phenoxymethylpenicillin,Powder for injection,1 g (=1 million IU),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
phenoxymethylpenicillin,Powder for injection,3 g (=3 million IU) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
phenoxymethylpenicillin,Powder for injection,2 g (as hydrochloride) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
phenoxymethylpenicillin,Injection,80 mg + 16 mg/mL in 5 mL ampoule,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
phenoxymethylpenicillin,Injection,80 mg + 16 mg/mL in 10 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
phenoxymethylpenicillin,Oral liquid,200 mg + 40 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,25
phenoxymethylpenicillin,Tablet,100 mg + 20 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
phenoxymethylpenicillin,Tablet,400 mg + 80 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
phenoxymethylpenicillin,Tablet,800 mg + 160 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
sulfamethoxazole +,trimethoprim,100 mg + 20 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,25
dysentery,Tablet,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dysentery,Tablet,200 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dysentery,Oral liquid,50 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
trimethoprim,Solid,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
trimethoprim,Solid,500 mg (anhydrous),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
trimethoprim,Powder for oral liquid,200 mg/5 mL (anhydrous),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
azithromycin,Powder for oral liquid,100 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
azithromycin,Solid,200 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
azithromycin,Solid,400 mg (as trihydrate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
dysentery,Powder for injection,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
dysentery,Powder for injection,500 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
dysentery,Powder for injection,1 g,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
dysentery,Powder for injection,2 g (as sodium) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
infections (severe),Powder for injection,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
infections (severe),Powder for injection,500 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
infections (severe),Powder for injection,1 g,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
infections (severe),Powder for injection,2 g (as sodium) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
infections (severe),Powder for injection,750 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
infections (severe),Powder for injection,1.5 g (as sodium) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
infections (severe),Oral liquid,250 mg/5 mL (anhydrous),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
infections (severe),Solution,2 mg/mL (as hyclate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
infections (severe),Solid,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
infections (severe),Solid,500 mg (as hydrochloride),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
moderate),Powder for oral liquid,125 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
moderate),Powder for oral liquid,250 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
moderate),Powder for injection,500 mg in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
moderate),Solid,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
moderate),Solid,500 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
moderate),Powder for injection,2 g (as sodium) + 250 mg (as sodium),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
moderate),Powder for injection,4 g (as sodium) +,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
infections (severe),Capsule,125 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
infections (severe),Capsule,250 mg (as hydrochloride),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
infections (severe),Powder for injection,1 g (as pentahydrate) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
the preferred choice for acute,Powder for injection,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
the preferred choice for acute,Powder for injection,500 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
the preferred choice for acute,Powder for injection,1 g (as hydrochloride) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
the preferred choice for acute,cefiderocol,1 g (as sulfate toxylate) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
the preferred choice for acute,ceftazidime,2 g + 0.5 g in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
the preferred choice for acute,ceftolozane,1 g + 0.5 g in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
the preferred choice for acute,Powder for injection,1 million IU (as colistemethate sodium) (equivalent,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
colistin,fosfomycin,2 g,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
colistin,fosfomycin,4 g (as sodium) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
colistin,Injection,2 mg/mL in 300 mL bag,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
o linezolid,Powder for oral liquid,100 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
o linezolid,Tablet,600 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
o linezolid,Tablet,150 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
o linezolid,meropenem,1 g (as trihydrate) + 1 g in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
o linezolid,Injection,500 mg/10 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
o linezolid,Powder for injection,500 000 IU (equivalent to 50 mg polymyxin B,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
o linezolid,clofazimine,50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
o linezolid,clofazimine,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
o linezolid,Tablet,25 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
o linezolid,Tablet,50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
o linezolid,Tablet,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
o linezolid,Oral liquid,20 mg/mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
rifampicin,Solid,150 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
rifampicin,Solid,300 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
rifampicin,Tablet,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
rifampicin,Tablet,400 mg (hydrochloride),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
ethambutol,Tablet,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
ethambutol + isoniazid + pyrazinamide +,Tablet,275 mg + 75 mg + 400 mg + 150 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
rifampicin,Tablet,275 mg + 75 mg + 150 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
rifampicin,Tablet,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
ethionamide,Tablet,125 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
ethionamide,Tablet,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
ethionamide,Tablet,300 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
isoniazid,Tablet,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
isoniazid,isoniazid,50 mg + 150 mg + 75 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
isoniazid,Tablet,75 mg + 150 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
isoniazid,Tablet,150 mg + 300 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
isoniazid + rifampicin,Tablet,50 mg + 75 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
isoniazid + rifampicin,isoniazid,300 mg + 300 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
isoniazid + rifampicin,Tablet,400 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
isoniazid + rifampicin,Tablet,500 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
pyrazinamide,Tablet,150 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
pyrazinamide,Solid,150 mg.*,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
rifabutin,Oral liquid,20 mg/mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
rifampicin,Tablet,150 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
rifampicin,Tablet,300 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
rifampicin,Injection,250 mg/mL (as sulfate) in 2 mL vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
rifampicin,Powder for oral liquid,250 mg (as trihydrate) + 62.5 mg (as potassium,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
rifampicin,Tablet,500 mg (as trihydrate) + 125 mg (as potassium salt),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
rifampicin,Tablet,20 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
rifampicin,clofazimine,50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
rifampicin,clofazimine,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
rifampicin,Therapeutic,Solid oral dosage form: 125 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
rifampicin,Therapeutic,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
rifampicin,Tablet,25 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
delamanid,Tablet,50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
delamanid,Tablet,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
delamanid,Tablet,125 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
delamanid,Tablet,250mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
delamanid,Tablet,500 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
delamanid,Tablet,750 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
levofloxacin,Tablet,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
levofloxacin,Tablet,600 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
linezolid,Tablet,150 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
linezolid,Therapeutic,Powder for injection: 500 mg (as trihydrate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
linezolid,Therapeutic,1 g (as trihydrate) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
linezolid,Tablet,400 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
moxifloxacin,Tablet,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
moxifloxacin,Powder,5.52 g in sachet (equivalent to 4 g,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,packet,25
p-aminosalicylate sodium,Tablet,200 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
p-aminosalicylate sodium,streptomycin,1 g (as sulfate) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
p-aminosalicylate sodium,Powder for injection,50 mg (liposomal complex) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
p-aminosalicylate sodium,Powder for injection,50 mg (as sodium deoxycholate) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
p-aminosalicylate sodium,Vaginal cream,1%,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,tube,20
p-aminosalicylate sodium,Vaginal cream,10%,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,tube,20
clotrimazole,Vaginal tablet,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
clotrimazole,Vaginal tablet,500 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
clotrimazole,Capsule,50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
clotrimazole,Injection,2 mg/mL in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
fluconazole,Oral liquid,50 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,25
fluconazole,Powder for oral liquid,50 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,25
fluconazole,Capsule,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
flucytosine,Infusion,2.5 g in 250 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
flucytosine,Oral liquid,125 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
griseofulvin,Solid,125 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
griseofulvin,Solid,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
griseofulvin,Capsule,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
griseofulvin,Oral liquid,10 mg/mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
griseofulvin,Lozenge,100 000 IU,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
griseofulvin,Oral liquid,100 000 IU/mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
nystatin,Pessary,100 000 IU,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
nystatin,Solid,500 000 IU,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
nystatin,Tablet,50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
nystatin,Tablet,200 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
nystatin,Powder for injection,200 mg in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
nystatin,Powder for oral liquid,40 mg/mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
nystatin,Therapeutic,Powder for injection: 50 mg (as sodium),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
nystatin,Therapeutic,100 mg (as sodium) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
nystatin,Therapeutic,Powder for injection: 250 mg (as sodium salt) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
nystatin,Tablet,300 mg (as sulfate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
nystatin,Oral liquid,50 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
lamivudine,Tablet,150 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
lamivudine,Tablet,300 mg (tenofovir disoproxil fumarate – equivalent to,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
lamivudine,Capsule,250 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
lamivudine,Oral liquid,50 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
zidovudine,Solution,10 mg/mL in 20 mL vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
zidovudine,Tablet,300 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
zidovudine,Tablet,600 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
zidovudine,Oral liquid,50 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
zidovudine,Tablet,50 mg (dispersible),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
zidovudine,Tablet,200 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
zidovudine,atazanavir,300 mg (as sulfate) + 100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
zidovudine,Tablet,75 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
zidovudine,Tablet,400 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
zidovudine,Tablet,800 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
darunavira,Solid,40 mg + 10 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
lopinavir + ritonavir,Tablet,100 mg + 25 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
lopinavir + ritonavir,Tablet,200 mg + 50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
lopinavir + ritonavir,ritonavir,25 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
lopinavir + ritonavir,ritonavir,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
lopinavir + ritonavir,Tablet,10 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dolutegravir a,Tablet,50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dolutegravir a,Granules,100 mg in sachet,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,packet,20
dolutegravir a,Tablet,25 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dolutegravir a,Tablet,400 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dolutegravir a,abacavir,120 mg (as sulfate) + 60 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
dolutegravir a,Tablet,50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate –,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
equivalent to 245 mg tenofovir disoproxil),Tablet,600 mg + 200 mg + 300 mg (tenofovir disoproxil fumarate,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
equivalent to 245 mg tenofovir disoproxil),Tablet,400 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
efavirenz + lamivudine + tenofovir,Tablet,30 mg + 60 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
efavirenz + lamivudine + tenofovir,Tablet,150 mg + 300 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
isoniazid + pyridoxine + sulfamethoxazole +,Tablet,300 mg + 25 mg + 800 mg + 160 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
trimethoprim,Injection,800 mg and 1 g in 10 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
trimethoprim,Solid,200 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
trimethoprim,Solid,400 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
trimethoprim,Solid,600 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
trimethoprim,Tablet,450 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
trimethoprim,Capsule,30 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
trimethoprim,Capsule,45 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
trimethoprim,Capsule,75 mg (as phosphate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
infection in critically ill hospitalized patients,Powder,50 mg/mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,packet,20
infection in critically ill hospitalized patients,Tablet,450 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
infection in critically ill hospitalized patients,Oral liquid,0.05 mg/mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
entecavir,Tablet,0.5 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
entecavir,Tablet,1 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
entecavir,Tablet,300 mg (tenofovir disoproxil fumarate – equivalent to,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
tenofovir disoproxil fumarate,Tablet,30 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
tenofovir disoproxil fumarate,Tablet,60 mg (as hydrochloride),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
tenofovir disoproxil fumarate,Tablet,60 mg + 400 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
tenofovir disoproxil fumarate,Tablet,100 mg + 40 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
glecaprevir + pibrentasvir,Granules,50 mg + 20 mg in sachet,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,packet,20
glecaprevir + pibrentasvir,Tablet,200 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
glecaprevir + pibrentasvir,Tablet,400 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
ravidasvir,Tablet,200 mg + 50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
ravidasvir,Tablet,400 mg + 100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
ravidasvir,Tablet,90 mg + 400 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
ravidasvir,Injection,800 mg and 1 g in 10 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
ravidasvir,ribavirin*,200 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
ravidasvir,ribavirin*,400 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
ravidasvir,ribavirin*,600 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
anti-viral medicines,Tablet,500 mg (furoate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
diloxanide a,Therapeutic,Oral liquid: 200 mg/5 mL (as benzoate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
diloxanide a,Powder for injection,50 mg (liposomal complex) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
diloxanide a,Powder for injection,50 mg (as sodium deoxycholate) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
diloxanide a,Injection,1.5 g/5 mL in 5 mL ampoule,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
diloxanide a,miltefosine,10 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
diloxanide a,miltefosine,50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
diloxanide a,paromomycin,750 mg of paromomycin base,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
diloxanide a,Injection,100 mg/mL in 30 mL vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
diloxanide a,Tablet,153 mg or 200 mg (as hydrochloride),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
diloxanide a,Oily injection,80 mg/mL in 1 mL ampoule,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
diloxanide a,Tablet,20 mg + 120 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
diloxanide a,Injection,"ampoules, containing 60 mg anhydrous artesunic acid",WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
diloxanide a,Rectal,50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
diloxanide a,Rectal,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
diloxanide a,Rectal,200 mg capsules (for,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
diloxanide a,Tablet,50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
diloxanide a,Tablet,25 mg + 67.5 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
diloxanide a,Tablet,50 mg + 135 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
diloxanide a,Tablet,100 mg + 270 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate,Tablet,25 mg + 55 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate,Tablet,100 mg + 220 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate,Granules,20 mg + 60 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,packet,20
as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate,Tablet,60 mg + 180 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate,Oral liquid,50 mg/5 mL (as phosphate or sulfate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate,Tablet,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate,Tablet,150 mg (as phosphate or sulfate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate,Tablet,20 mg + 160 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate,Tablet,40 mg + 320 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dihydroartemisinin + piperaquine phosphate a,Capsule,100 mg (as hydrochloride or hyclate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dihydroartemisinin + piperaquine phosphate a,doxycycline*,100 mg (as monohydrate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
dihydroartemisinin + piperaquine phosphate a,Tablet,250 mg (as hydrochloride),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dihydroartemisinin + piperaquine phosphate a,Tablet,7.5 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dihydroartemisinin + piperaquine phosphate a,Tablet,15 mg (as diphosphate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dihydroartemisinin + piperaquine phosphate a,Injection,300 mg/mL (hydrochloride) in 2 mL ampoule,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
dihydroartemisinin + piperaquine phosphate a,Tablet,300 mg (sulfate) or 300 mg (bisulfate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dihydroartemisinin + piperaquine phosphate a,Tablet,500 mg + 25 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dihydroartemisinin + piperaquine phosphate a,Oral liquid,50 mg/5 mL (as phosphate or sulfate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
dihydroartemisinin + piperaquine phosphate a,Tablet,150 mg (as phosphate or sulfate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
dihydroartemisinin + piperaquine phosphate a,Solid,100 mg (as hydrochloride or hyclate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,20
doxycycline a,Tablet,250 mg (as hydrochloride),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Tablet,100 mg (as hydrochloride),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Tablet,250 mg + 12.5 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Tablet,500 mg + 25 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Tablet,25 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Tablet,500 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Injection,80 mg + 16 mg/mL in 5 mL ampoule,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
mefloquine a,Injection,80 mg +,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
mefloquine a,Oral liquid,200 mg + 40 mg/5 mL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,bottle,20
mefloquine a,Tablet,100 mg + 20 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Tablet,400 mg + 80 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Tablet,800 mg + 160 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Tablet,200 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Tablet,300 mg (as isethionate),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Tablet,600 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Powder for injection,300 mg (as isetionate) in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
mefloquine a,Powder for injection,1 g in vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
mefloquine a,Injection,200 mg/mL (hydrochloride) in 50 mL bottle,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
mefloquine a,Injection,180 mg/5 mL in 5 mL ampoule (3.6% solution),WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,20
mefloquine a,Tablet,30 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Tablet,120 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
mefloquine a,Tablet,12.5 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,20
benznidazole,Tablet,50 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
benznidazole,Tablet,100 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
benznidazole,nifurtimox,30 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,25
benznidazole,nifurtimox,120 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,25
benznidazole,Tablet,3 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,strip,25
benznidazole,ansuvimab,400 mg,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,25
benznidazole,Injection,241.7 mg + 241.7 mg + 241.7 mg in 14.5 mL vial,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,vial,25
benznidazole,The,living guideline is available online at: https://app.magicapp.org/#/guideline/nBkO1E,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,25
benznidazole,The,living guideline is available online at: https://app.magicapp.org/#/guideline/L6RxYL,WHO EML 2023,Complementary,6. ANTI-INFECTIVE MEDICINES,unit,25
benznidazole,Tablet,300 mg to 500 mg,WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,strip,25
benznidazole,Oral liquid,100 mg/5 mL,WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,bottle,25
benznidazole,Tablet,200 mg,WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,strip,25
benznidazole,Tablet,400 mg,WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,strip,25
benznidazole,Oral liquid,120 mg/5 mL or 125 mg/5 mL*,WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,bottle,25
benznidazole,Oral liquid,250 mg/5 mL,WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,bottle,25
paracetamol (acetaminophen),Suppository,250 mg,WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,unit,20
paracetamol (acetaminophen),Tablet,250 mg,WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,strip,20
paracetamol (acetaminophen),Tablet,325 mg,WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,strip,20
paracetamol (acetaminophen),Tablet,500 mg,WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,strip,20
paracetamol (acetaminophen),Tablet,"100 mg, 250 mg",WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,strip,20
paracetamol (acetaminophen),Tablet,50 mg,WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,strip,20
paracetamol (acetaminophen),Tablet,20 mg,WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,strip,20
paracetamol (acetaminophen),Tablet,40 mg (hydrochloride),WHO EML 2023,Core,7. ANTIMIGRAINE MEDICINES,strip,20
paracetamol (acetaminophen),Oral liquid,10 mg/mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,bottle,20
paracetamol (acetaminophen),Powder for injection,50 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
paracetamol (acetaminophen),Powder for injection,100 mg (as sodium salt) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
azathioprine,Tablet,25 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
azathioprine,Tablet,50 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
azathioprine,Capsule,25 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
azathioprine,ciclosporin,50 mg/mL in 1 mL ampoule,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
azathioprine,Oral liquid,100 mg/mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,bottle,20
azathioprine,Capsule,0.5 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
azathioprine,Capsule,0.75 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
azathioprine,Capsule,1 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
azathioprine,Capsule,2 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
tacrolimus,Granules,0.2 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,packet,20
tacrolimus,Granules,1 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,packet,20
tacrolimus,Injection,5 mg/mL in 1 mL vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
tacrolimus,Concentrate,1 mg/mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
tacrolimus,Concentrate,2 mg/mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
arsenic trioxide,asparaginase*,10 000 IU in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
arsenic trioxide,Injection,45 mg/0.5 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
arsenic trioxide,Injection,180 mg/2 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
bendamustine,Powder for injection,15 000 IU (as sulfate) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
bleomycin,Injection,3 mg/mL in 10 mL ampoule,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
bleomycin,Injection,7.5 mg/mL in 2 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
bleomycin,Tablet,5 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
bleomycin,Tablet,15 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
bleomycin,Tablet,25 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
calcium folinate (leucovorin calcium),Tablet,150 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
calcium folinate (leucovorin calcium),Tablet,500 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
capecitabine,Injection,50 mg/5 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
capecitabine,Injection,150 mg/15 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
capecitabine,Injection,450 mg/45 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
capecitabine,Tablet,2 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
chlorambucil,Injection,10 mg/10 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
chlorambucil,Injection,20 mg/20 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
chlorambucil,Injection,50 mg/50 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
chlorambucil,Powder for injection,500 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
chlorambucil,Powder for injection,1 g,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
chlorambucil,Powder for injection,2 g in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
chlorambucil,Solid,25 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
chlorambucil,Solid,50 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
cyclophosphamide,Injection,100 mg/mL in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
cyclophosphamide,Powder for injection,100 mg in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
cyclophosphamide,Powder for injection,100 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
cyclophosphamide,Powder for injection,200 mg in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
dacarbazine,Powder for injection,500 micrograms in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
dacarbazine,Injection,2 mg/mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
dacarbazine,Injection,5 mg/mL (as hydrochloride) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
dacarbazine,Powder for injection,20 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
dacarbazine,Powder for injection,50 mg (as hydrochloride) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
daunorubicin,Injection,20 mg/mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
daunorubicin,Injection,40 mg/mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
daunorubicin,Injection,2 mg/mL (hydrochloride) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
daunorubicin,Powder for injection,10 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
daunorubicin,Powder for injection,50 mg (hydrochloride) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
doxorubicin,Injection,"2 mg/mL (hydrochloride) in 10 mL, 25 mL vial",WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
doxorubicin (as pegylated liposomal),Capsule,"50 mg, 100 mg",WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
doxorubicin (as pegylated liposomal),Injection,20 mg/mL in 5 mL ampoule,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
doxorubicin (as pegylated liposomal),Powder for injection,100 mg (as phosphate) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
etoposide,Powder for injection,50 mg (phosphate) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
etoposide,Tablet,10 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
etoposide,Injection,50 mg/mL in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
etoposide,Powder for injection,200 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
etoposide,Powder for injection,1 g in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
gemcitabine,Solid,100 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
gemcitabine,Solid,200 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
gemcitabine,Solid,300 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
gemcitabine,Solid,400 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
hydroxycarbamide (hydroxyurea),Powder for injection,500 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
hydroxycarbamide (hydroxyurea),Powder for injection,1 g,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
hydroxycarbamide (hydroxyurea),Powder for injection,2 g in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
ifosfamide,Injection,40 mg/2 mL in 2 mL vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
ifosfamide,Injection,100 mg/5 mL in 5 mL vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
irinotecan,Tablet,2 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
irinotecan,melphalan,50 mg in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
irinotecan,Tablet,50 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
irinotecan,Oral liquid,20 mg/mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,bottle,20
mercaptopurine,Concentrated,1000 mg/10 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
mercaptopurine,Injection,50mg/2 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
mercaptopurine,Powder for injection,50 mg (as sodium) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
mercaptopurine,Tablet,2.5 mg (as sodium),WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
methotrexate,Injection,50 mg/10 mL in 10 mL vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
methotrexate,Injection,100 mg/20 mL in 20 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
methotrexate,oxaliplatin,50 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
methotrexate,oxaliplatin,100 mg in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
methotrexate,Injection,6 mg/mL in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
paclitaxel,Injection,3750 units/5 mL in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
paclitaxel,Powder for injection,3750 units in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
paclitaxel,Capsule,50 mg (as hydrochloride),WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
paclitaxel,Tablet,270 mg (containing tetra-arsenic tetra-sulfide 30 mg),WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
paclitaxel,Solid,40 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
paclitaxel,Injection,10 mg/10 mL (sulfate) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
paclitaxel,Powder for injection,10 mg (sulfate) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
vinblastine,Injection,1 mg/mL (sulfate),WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
vinblastine,Injection,2 mg/2 mL (sulfate) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
vinblastine,Powder for injection,1 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
vinblastine,Powder for injection,5 mg (sulfate) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
vincristine,Capsule,20 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
vincristine,Capsule,30 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
vincristine,Capsule,80 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
vincristine,Injection,"10 mg/mL in 1 mL, 5 mL vial",WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
vinorelbine,Capsule,10 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
vinorelbine,Powder for injection,3.5 mg in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
bortezomib,Tablet,20 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
bortezomib,Tablet,50 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
bortezomib,Tablet,70 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
bortezomib,Tablet,80 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
bortezomib,Tablet,100 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
bortezomib,Tablet,140 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
dasatinib,Tablet,"100 mg, 150 mg",WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
dasatinib,Tablet,2.5 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
dasatinib,Tablet,5 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
dasatinib,Tablet,7.5 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
dasatinib,Tablet,10 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
dasatinib,everolimus,2 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
dasatinib,everolimus,3 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
dasatinib,everolimus,5 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
dasatinib,Capsule,140 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
ibrutinib,Solid,100 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
ibrutinib,Solid,400 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
leukaemia,Capsule,150 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
leukaemia,Capsule,200 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
nilotinib,Injection,100 mg/10 mL in 10 mL vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
nilotinib,Powder for injection,60 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
nilotinib,Powder for injection,150 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
nilotinib,Powder for injection,440 mg in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
nilotinib,Injection,120 micrograms/0.2 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
nilotinib,Injection,300 micrograms/0.5 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
nilotinib,Injection,300 micrograms/mL in 1 mL vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
nilotinib,Injection,480 micrograms/1.6,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
regimens,Capsule,25 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
lenalidomide,Therapeutic,− Metastatic melanoma,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
lenalidomide,Injection,6 mg/0.6 mL in pre-filled syringe,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
regimens,Capsule,50 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
thalidomide,Therapeutic,− Metastatic castration-resistant prostate cancer,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
thalidomide,Therapeutic,− Early stage breast cancer,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
thalidomide,Tablet,50 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
thalidomide,Injection,4 mg/mL (as disodium phosphate salt) in 1 mL ampoule,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
thalidomide,Oral liquid,2 mg/5 mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,bottle,20
thalidomide,Tablet,2 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
thalidomide,Tablet,4 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
dexamethasone,Powder for injection,100 mg (as sodium succinate) in vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
hydrocortisone,Injection,7.5 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
hydrocortisone,Injection,22.5 mg in pre-filled syringe,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
hydrocortisone,Injection,40 mg/mL (as sodium succinate) in 1 mL single-dose,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
hydrocortisone,Oral liquid,5 mg/mL,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,bottle,20
hydrocortisone,Tablet,5 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
hydrocortisone,Tablet,25 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
hydrocortisone,Therapeutic,− Chronic lymphocytic leukaemia,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
hydrocortisone,Tablet,10 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
hydrocortisone,Tablet,20 mg (as citrate),WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
tamoxifen,Tablet,100 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
tamoxifen,Tablet,300 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
tamoxifen,Injection,100 mg/mL in 4 mL and 10 mL ampoules,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
tamoxifen,Tablet,400 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
tamoxifen,Tablet,600 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,strip,20
mesna,Powder,1.5 mg,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,packet,20
mesna,Powder,7.5 mg in,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,packet,20
rasburicase,Concentrate solution for infusion,4 mg/5 mL in 5 mL vial,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,vial,20
rasburicase,zoledronic,4 mg/100 mL in 100 mL bottle,WHO EML 2023,Complementary,8. IMMUNOMODULATORS AND ANTINEOPLASTICS,unit,20
statement on the community-based management of severe acute,Oral liquid,equivalent to 25 mg iron (as sulfate)/mL,WHO EML 2023,Core,10. MEDICINES AFFECTING THE BLOOD,bottle,20
ferrous salt,Tablet,equivalent to 60 mg iron,WHO EML 2023,Core,10. MEDICINES AFFECTING THE BLOOD,strip,20
ferrous salt,Tablet,equivalent to 60 mg elemental iron + 400 micrograms folic,WHO EML 2023,Core,10. MEDICINES AFFECTING THE BLOOD,strip,20
ferrous salt,Tablet,equivalent to 60 mg elemental iron + 2.8 mg folic acid.**,WHO EML 2023,Core,10. MEDICINES AFFECTING THE BLOOD,strip,20
ferrous salt,Tablet,400 micrograms*,WHO EML 2023,Core,10. MEDICINES AFFECTING THE BLOOD,strip,20
ferrous salt,Tablet,1 mg,WHO EML 2023,Core,10. MEDICINES AFFECTING THE BLOOD,strip,20
ferrous salt,Tablet,5 mg,WHO EML 2023,Core,10. MEDICINES AFFECTING THE BLOOD,strip,20
tube defects,Injection,"1 mg/mL (as acetate, as hydrochloride or as sulfate) in",WHO EML 2023,Core,10. MEDICINES AFFECTING THE BLOOD,vial,20
hydroxocobalamin,Injection,pre-filled syringe,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,vial,20
hydroxocobalamin,Capsule,110 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
hydroxocobalamin,Capsule,150 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
hydroxocobalamin,Injection,ampoule or pre-filled syringe,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,vial,20
hydroxocobalamin,Injection,1000 IU/mL,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,vial,20
hydroxocobalamin,Injection,5000 IU/mL,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,vial,20
hydroxocobalamin,Injection,20 000 IU/mL in 1 mL,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,vial,20
heparin sodium,Injection,1 mg/mL,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,vial,20
heparin sodium,Injection,10 mg/mL in ampoule,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,vial,20
phytomenadione,Tablet,10 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
phytomenadione,Injection,10 mg/mL in 5 mL ampoule,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,vial,20
phytomenadione,Injection,100 mg/mL in 10 mL ampoule,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,vial,20
phytomenadione,Tablet,1 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
phytomenadione,Tablet,2 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
phytomenadione,Tablet,5 mg (sodium),WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
phytomenadione,Injection,4 micrograms/mL (as acetate) in 1 mL ampoule,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,vial,20
phytomenadione,Nasal,10 micrograms (as acetate) per dose,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,unit,20
phytomenadione,Injection,1000 IU/mL,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,vial,20
phytomenadione,Injection,5000 IU/mL in 1 mL ampoule,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,vial,20
phytomenadione,Tablet,0.5 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
phytomenadione,Tablet,100 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
phytomenadione,Tablet,125 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
phytomenadione,Tablet,250 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
phytomenadione,Tablet,400 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
phytomenadione,Tablet,500 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
phytomenadione,Tablet,90 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
phytomenadione,Tablet,180 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
phytomenadione,Tablet,360 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,strip,20
phytomenadione,deferoxamine,500 mg (mesilate) in vial,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,unit,20
phytomenadione,hydroxycarbamide,100 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,unit,20
phytomenadione,hydroxycarbamide,200 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,unit,20
phytomenadione,hydroxycarbamide,500 mg,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,unit,20
phytomenadione,hydroxycarbamide,1 g,WHO EML 2023,Complementary,10. MEDICINES AFFECTING THE BLOOD,unit,20
whole blood,Injection,250 micrograms in single-dose vial,WHO EML 2023,Core,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,vial,20
whole blood,Injection,150 IU/mL in vial,WHO EML 2023,Core,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,vial,20
whole blood,Injection,500 IU in vial,WHO EML 2023,Core,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,vial,20
whole blood,Intramuscular,16% protein solution,WHO EML 2023,Complementary,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,unit,20
whole blood,Subcutaneous,15%,WHO EML 2023,Complementary,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,unit,20
whole blood,Subcutaneous,16% protein solution,WHO EML 2023,Complementary,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,unit,20
normal immunoglobulin,Intravenous,5%,WHO EML 2023,Complementary,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,unit,20
normal immunoglobulin,Intravenous,10% protein solution,WHO EML 2023,Complementary,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,unit,20
normal immunoglobulin,coagulation,250 IU,WHO EML 2023,Complementary,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,unit,20
normal immunoglobulin,coagulation,500 IU,WHO EML 2023,Complementary,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,unit,20
normal immunoglobulin,coagulation,1000 IU in vial,WHO EML 2023,Complementary,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,unit,20
normal immunoglobulin,Therapeutic,Powder for injection: 500 IU,WHO EML 2023,Complementary,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,unit,20
normal immunoglobulin,Therapeutic,1000 IU in vial,WHO EML 2023,Complementary,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,unit,20
normal immunoglobulin,Therapeutic,Injectable solution: 6%,WHO EML 2023,Complementary,11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES,unit,20
normal immunoglobulin,Tablet,1.25 mg,WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,strip,20
normal immunoglobulin,Tablet,5 mg,WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,strip,20
normal immunoglobulin,glyceryl,500 micrograms,WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,unit,20
normal immunoglobulin,isosorbide,5 mg,WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,unit,20
normal immunoglobulin,Tablet,40 mg,WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,strip,20
normal immunoglobulin,Tablet,80 mg (hydrochloride),WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,strip,20
normal immunoglobulin,Injection,250 micrograms/mL in 2 mL ampoule,WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,vial,20
normal immunoglobulin,Oral liquid,50 micrograms/mL,WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,bottle,20
normal immunoglobulin,Tablet,62.5 micrograms,WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,strip,20
normal immunoglobulin,Tablet,250 micrograms,WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,strip,20
normal immunoglobulin,Injection,100 micrograms/mL (as acid tartrate or hydrochloride),WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,vial,20
epinephrine (adrenaline),Injection,20 mg/mL (hydrochloride) in 5 mL ampoule,WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,vial,20
epinephrine (adrenaline),Injection,2.5 mg/mL (hydrochloride) in 2 mL ampoule,WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,vial,20
verapamil,Tablet,40 mg,WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,strip,20
verapamil,Tablet,80 mg (hydrochloride),WHO EML 2023,Core,12. CARDIOVASCULAR MEDICINES,strip,20
verapamil,Injection,50 mg/mL (hydrochloride) in 3 mL ampoule,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,vial,20
amiodarone,Tablet,100 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
amiodarone,Tablet,200 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
amiodarone,Tablet,400 mg (hydrochloride),WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
amiodarone,Therapeutic,"Tablet: 5 mg (as maleate, mesylate or besylate)",WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,unit,20
amiodarone,Tablet,1.25 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
amiodarone,Tablet,5 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
amiodarone,Oral liquid,1 mg/mL (as hydrogen maleate),WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,bottle,20
amiodarone,Tablet,2.5 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
amiodarone,Tablet,10 mg (as hydrogen maleate),WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
amiodarone,Powder for injection,20 mg (hydrochloride) in ampoule,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,vial,20
amiodarone,Tablet,25 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
amiodarone,Tablet,50 mg (hydrochloride),WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
amiodarone,Therapeutic,Oral liquid: 50 mg/5 mL,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,unit,20
amiodarone,Solid,12.5 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,unit,20
amiodarone,Solid,25 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,unit,20
amiodarone,Tablet,10 mg + 12.5 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
amiodarone,Tablet,20 mg + 12.5 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
amiodarone,Tablet,20 mg + 25 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,25 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,50 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,100 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,250 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,40 mg + 12.5 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,80 mg + 12.5 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,80 mg + 25 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),sodium,50 mg in ampoule,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,unit,20
hydrochlorothiazide),Therapeutic,Tablet: 1.25 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,unit,20
hydrochlorothiazide),Therapeutic,5 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,unit,20
hydrochlorothiazide),Injection,250 micrograms/mL in 2 mL ampoule,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,vial,20
hydrochlorothiazide),Oral liquid,50 micrograms/mL,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,bottle,20
hydrochlorothiazide),Tablet,62.5 micrograms,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,250 micrograms,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,2.5 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,5 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,10 mg (as hydrogen maleate),WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Injection,"10 mg/mL in 2 mL, 5 mL ampoule",WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,vial,20
hydrochlorothiazide),Oral liquid,20 mg/5 mL,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,bottle,20
hydrochlorothiazide),Oral liquid,50 mg/5 mL,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,bottle,20
hydrochlorothiazide),Tablet,20 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,40 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Injection,100 micrograms/mL in 1 mL ampoule,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,vial,20
hydrochlorothiazide),Tablet,125 micrograms,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,250 mg micrograms,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Injection,40 mg/mL (hydrochloride) in 5 mL vial,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,vial,20
hydrochlorothiazide),Tablet,75 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Tablet,300 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),alteplase,10 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,unit,20
hydrochlorothiazide),alteplase,20 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,unit,20
hydrochlorothiazide),alteplase,50 mg in vial,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,unit,20
hydrochlorothiazide),streptokinase,1.5 million IU in vial,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,unit,20
hydrochlorothiazide),Tablet,10 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
hydrochlorothiazide),Therapeutic,Tablet: 100 mg + 20 mg + 2.5 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,unit,20
hydrochlorothiazide),Therapeutic,100 mg + 20 mg + 5 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,unit,20
hydrochlorothiazide),Tablet,100 mg + 20 mg + 5 mg + 50 mg + 12.5 mg,WHO EML 2023,Complementary,12. CARDIOVASCULAR MEDICINES,strip,20
atorvastatin),Cream,2% (nitrate),WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,tube,20
and triazole derivatives) excluding combinations,selenium,2%,WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,unit,25
and triazole derivatives) excluding combinations,sodium,15%,WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,unit,25
and triazole derivatives) excluding combinations,terbinafine,1% (hydrochloride),WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,unit,25
and triazole derivatives) excluding combinations,Cream,2% (as calcium),WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,tube,25
mupirocin,Ointment,2%,WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,tube,20
mupirocin,potassium,1:10 000,WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,unit,20
mupirocin,Cream,1%,WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,tube,20
silver sulfadiazine a,Cream,0.1% (as valerate),WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,tube,20
silver sulfadiazine a,Cream,1% (acetate),WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,tube,20
silver sulfadiazine a,benzoyl,5%,WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,unit,20
silver sulfadiazine a,Cream,50 micrograms/mL (0.005%),WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,tube,20
silver sulfadiazine a,Lotion,50 micrograms/mL (0.005%),WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,unit,20
silver sulfadiazine a,coal,5%,WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,unit,20
silver sulfadiazine a,fluorouracil,5%,WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,unit,20
silver sulfadiazine a,Therapeutic,Solution: 10% to 25%,WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,unit,20
silver sulfadiazine a,salicylic,5%,WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,unit,20
silver sulfadiazine a,urea,5%,WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,unit,20
silver sulfadiazine a,urea,10%,WHO EML 2023,Core,13. DERMATOLOGICAL MEDICINES,unit,20
silver sulfadiazine a,Tablet,2.5 mg,WHO EML 2023,Complementary,13. DERMATOLOGICAL MEDICINES,strip,20
silver sulfadiazine a,Tablet,10 mg (as sodium),WHO EML 2023,Complementary,13. DERMATOLOGICAL MEDICINES,strip,20
silver sulfadiazine a,Lotion,25%,WHO EML 2023,Complementary,13. DERMATOLOGICAL MEDICINES,unit,20
silver sulfadiazine a,Cream,5%,WHO EML 2023,Complementary,13. DERMATOLOGICAL MEDICINES,tube,20
permethrin,Lotion,1%,WHO EML 2023,Complementary,13. DERMATOLOGICAL MEDICINES,unit,20
permethrin,fluorescein,1% (sodium salt),WHO EML 2023,Core,14. DIAGNOSTIC AGENTS,unit,20
permethrin,Eye,0.5%,WHO EML 2023,Core,14. DIAGNOSTIC AGENTS,unit,20
permethrin,Solution,5 g to 8 g iodine in 100 mL to 250 mL,WHO EML 2023,Complementary,14. DIAGNOSTIC AGENTS,unit,20
permethrin,Solution,5% (digluconate),WHO EML 2023,Core,15. ANTISEPTICS AND DISINFECTANTS,unit,20
permethrin,Therapeutic,Solution: 70% (denatured),WHO EML 2023,Core,15. ANTISEPTICS AND DISINFECTANTS,unit,20
permethrin,Therapeutic,Solution: 10% (equivalent to 1% available iodine),WHO EML 2023,Core,15. ANTISEPTICS AND DISINFECTANTS,unit,20
permethrin,Solution,containing ethanol 80% volume/volume,WHO EML 2023,Core,15. ANTISEPTICS AND DISINFECTANTS,unit,20
alcohol based hand rub,Solution,containing isopropyl alcohol 75% volume/volume,WHO EML 2023,Core,15. ANTISEPTICS AND DISINFECTANTS,unit,20
alcohol based hand rub,Liquid,(0.1% available chlorine) for solution,WHO EML 2023,Core,15. ANTISEPTICS AND DISINFECTANTS,unit,20
alcohol based hand rub,chlorine,(0.1% available chlorine) for solution,WHO EML 2023,Core,15. ANTISEPTICS AND DISINFECTANTS,unit,20
alcohol based hand rub,Solid,(0.1% available chlorine) for solution,WHO EML 2023,Core,15. ANTISEPTICS AND DISINFECTANTS,unit,20
o chloroxylenol,Solution,4.8%,WHO EML 2023,Core,15. ANTISEPTICS AND DISINFECTANTS,unit,20
derivatives),glutaral,2%,WHO EML 2023,Core,15. ANTISEPTICS AND DISINFECTANTS,unit,20
derivatives),Tablet,5 mg (hydrochloride),WHO EML 2023,Core,16. DIURETICS,strip,20
derivatives),Therapeutic,Oral liquid: 20 mg/5 mL,WHO EML 2023,Core,16. DIURETICS,unit,20
derivatives),Therapeutic,50 mg/5 mL,WHO EML 2023,Core,16. DIURETICS,unit,20
derivatives),Solid,25 mg,WHO EML 2023,Core,16. DIURETICS,unit,20
derivatives),mannitol,10%,WHO EML 2023,Core,16. DIURETICS,unit,20
derivatives),mannitol,20%,WHO EML 2023,Core,16. DIURETICS,unit,20
derivatives),Tablet,25 mg,WHO EML 2023,Core,16. DIURETICS,strip,20
derivatives),Therapeutic,Tablet (scored): 25 mg,WHO EML 2023,Complementary,16. DIURETICS,unit,20
derivatives),mannitol,10%,WHO EML 2023,Complementary,16. DIURETICS,unit,20
derivatives),mannitol,20%,WHO EML 2023,Complementary,16. DIURETICS,unit,20
derivatives),Oral liquid,5 mg/5 mL,WHO EML 2023,Complementary,16. DIURETICS,bottle,20
derivatives),Oral liquid,10 mg/5 mL,WHO EML 2023,Complementary,16. DIURETICS,bottle,20
derivatives),Oral liquid,25 mg/5 mL,WHO EML 2023,Complementary,16. DIURETICS,bottle,20
derivatives),Tablet,25 mg,WHO EML 2023,Complementary,16. DIURETICS,strip,20
derivatives),Powder for injection,40 mg in vial,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,vial,20
derivatives),Powder for oral liquid,20 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,bottle,20
derivatives),Powder for oral liquid,40 mg sachets,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,bottle,20
derivatives),Solid,10 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
derivatives),Solid,20 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
derivatives),Solid,40 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
inhibitors) excluding combinations,Injection,25 mg/mL (as hydrochloride) in 2 mL ampoule,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,vial,20
inhibitors) excluding combinations,Oral liquid,75 mg/5 mL (as hydrochloride),WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,bottle,20
antagonists) excluding combinations,Injection,4 mg/mL (as disodium phosphate salt) in 1 mL ampoule,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,vial,20
antagonists) excluding combinations,Oral liquid,0.5 mg/5 mL,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,bottle,20
antagonists) excluding combinations,Oral liquid,2 mg/5 mL,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,bottle,20
antagonists) excluding combinations,Solid,0.5 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
antagonists) excluding combinations,Solid,0.75 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
antagonists) excluding combinations,Solid,1.5 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
antagonists) excluding combinations,Solid,4 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
antagonists) excluding combinations,Injection,5 mg/mL (hydrochloride) in 2 mL ampoule,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,vial,20
antagonists) excluding combinations,Oral liquid,5 mg/5 mL,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,bottle,20
metoclopramide a,Tablet,10 mg (hydrochloride),WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,strip,20
metoclopramide a,Therapeutic,Oral liquid: 4 mg base/5 mL,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
metoclopramide a,Capsule,80 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,strip,20
metoclopramide a,Capsule,125 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,strip,20
metoclopramide a,Capsule,165 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,strip,20
aprepitant,Powder,125 mg in sachet,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,packet,20
aprepitant,Suppository,500 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
aprepitant,Tablet,500 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,strip,20
aprepitant,Retention,100 mg/60 mL,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,Suppository,25 mg (acetate),WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,prednisolone,20 mg/100 mL (as sodium phosphate),WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,Therapeutic,Tablet: 7.5 mg (sennosides) (or traditional dosage forms),WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,glucose,75 m,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,sodium,75 m or mmol/L,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,chloride,65 m or mmol/L,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,potassium,20 m or mmol/L,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,citrate,10 mmol/L,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,osmolarity,245 mOsm/L,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,oral,13.5 g/L,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,sodium,2.6 g/L,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,potassium,1.5 g/L,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,trisodium,2.9 g/L,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,Solid,20 mg,WHO EML 2023,Complementary,17. GASTROINTESTINAL MEDICINES,unit,20
hydrocortisone,Tablet,100 micrograms (acetate),WHO EML 2023,Core,18. MEDICINES FOR ENDOCRINE DISORDERS,strip,20
hydrocortisone,Tablet,5 mg,WHO EML 2023,Core,18. MEDICINES FOR ENDOCRINE DISORDERS,strip,20
hydrocortisone,Tablet,10 mg,WHO EML 2023,Core,18. MEDICINES FOR ENDOCRINE DISORDERS,strip,20
hydrocortisone,Tablet,20 mg,WHO EML 2023,Core,18. MEDICINES FOR ENDOCRINE DISORDERS,strip,20
hydrocortisone,Injection,200 mg (enanthate) in 1 mL ampoule,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,vial,20
hydrocortisone,Therapeutic,Tablet: 5 mg,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,unit,20
hydrocortisone,Injection,40 IU/mL in 10 mL vial,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,vial,20
hydrocortisone,Injection,100 IU/mL in 10 mL vial,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,vial,20
hydrocortisone,Solid,(controlled-release tablets) 30 mg,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,unit,20
hydrocortisone,Solid,60 mg,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,unit,20
hydrocortisone,Therapeutic,80 mg,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,unit,20
hydrocortisone,Tablet,500 mg (hydrochloride),WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,strip,20
hydrocortisone,Injection,1 mg/mL,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,vial,20
hydrocortisone,Oral liquid,50 mg/mL,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,bottle,20
hydrocortisone,Tablet,50 mg,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,strip,20
hydrocortisone,Tablet,25 micrograms,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,strip,20
hydrocortisone,Tablet,50 micrograms,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,strip,20
hydrocortisone,Tablet,100 micrograms,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,strip,20
levothyroxine,Tablet,60 mg,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,strip,20
levothyroxine,Tablet,"5mg, 10mg, 20mg",WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,strip,20
levothyroxine,Tablet,50 mg,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,strip,20
levothyroxine,Oral liquid,about 130 mg total iodine/mL,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,bottle,20
levothyroxine,Therapeutic,"Tablet: 5mg, 10mg, 20mg",WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,unit,20
available,Therapeutic,Tablet: 0.5 mg,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,unit,20
available,Therapeutic,1 mg,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,unit,20
available,Injection,0.05 mg/mL,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,vial,20
available,Injection,0.1 mg/mL,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,vial,20
octreotide,Injection,20 mg (as acetate) in vial plus,WHO EML 2023,Complementary,18. MEDICINES FOR ENDOCRINE DISORDERS,vial,20
octreotide,Injection,"40 IU/mL in 1.25 mL, 2.5 mL vial",WHO EML 2023,Core,19. IMMUNOLOGICALS,vial,20
octreotide,Injection,100 IU/mL in 2.5 mL,WHO EML 2023,Core,19. IMMUNOLOGICALS,vial,20
octreotide,Injection,10 000 IU,WHO EML 2023,Core,19. IMMUNOLOGICALS,vial,20
octreotide,Injection,20 000 IU in vial,WHO EML 2023,Core,19. IMMUNOLOGICALS,vial,20
octreotide,Injection,150 IU/mL,WHO EML 2023,Core,19. IMMUNOLOGICALS,vial,20
octreotide,Injection,200 IU/mL,WHO EML 2023,Core,19. IMMUNOLOGICALS,vial,20
octreotide,Injection,300 IU/mL,WHO EML 2023,Core,19. IMMUNOLOGICALS,vial,20
octreotide,Injection,400 IU/mL in vial,WHO EML 2023,Core,19. IMMUNOLOGICALS,vial,20
octreotide,https,//www.who.int/teams/immunization-vaccines-and-biologicals/policies/position-papers,WHO EML 2023,Core,19. IMMUNOLOGICALS,unit,20
octreotide,https,//www.who.int/teams/immunization-vaccines-and-biologicals/policies/who-recommendations-for-routine-immunization---,WHO EML 2023,Core,19. IMMUNOLOGICALS,unit,20
varicella vaccine,Injection,10 mg/mL (besylate),WHO EML 2023,Core,20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS,vial,10
varicella vaccine,Injection,500 micrograms/mL (methylsulfate) in 1 mL ampoule,WHO EML 2023,Core,20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS,vial,10
neostigmine,Tablet,15 mg (bromide),WHO EML 2023,Core,20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS,strip,20
neostigmine,Injection,50 mg/mL (chloride) in 2 mL ampoule,WHO EML 2023,Core,20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS,vial,20
suxamethonium,Powder for injection,"(chloride), in vial",WHO EML 2023,Core,20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS,vial,20
suxamethonium,Therapeutic,Powder for injection: 10 mg (bromide) in vial,WHO EML 2023,Core,20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS,unit,20
suxamethonium,Injection,1 mg in 1 mL ampoule,WHO EML 2023,Complementary,20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS,vial,20
pyridostigmine,Tablet,60 mg (bromide),WHO EML 2023,Complementary,20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS,strip,20
pyridostigmine,Powder for injection,10 mg (bromide) in vial,WHO EML 2023,Complementary,20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS,vial,20
pyridostigmine,aciclovir,3% w/w,WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
pyridostigmine,Solution,1.5%,WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
azithromycin,Ointment,0.5%,WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,tube,20
erythromycin,Therapeutic,Solution (eye drops): 0.3% (sulfate),WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
erythromycin,Suspension,5%,WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
natamycin,Solution,0.3%,WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
natamycin,Eye,1% (hydrochloride),WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
natamycin,Solution,0.5% (sodium phosphate),WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
natamycin,Solution,0.5% (hydrochloride),WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
anaesthetics) excluding cocaine and combinations,Tablet,250 mg,WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,strip,20
anaesthetics) excluding cocaine and combinations,latanoprost,50 micrograms/mL,WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
anaesthetics) excluding cocaine and combinations,Therapeutic,Solution (eye drops): 2%,WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
anaesthetics) excluding cocaine and combinations,Therapeutic,4% (hydrochloride or nitrate),WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
anaesthetics) excluding cocaine and combinations,Solution,0.25%,WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
anaesthetics) excluding cocaine and combinations,Solution,0.5% (as hydrogen maleate),WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
agents) excluding combinations,Therapeutic,Solution (eye drops): 0.1%,WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
agents) excluding combinations,Therapeutic,0.5%,WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
agents) excluding combinations,Therapeutic,1% (sulfate),WHO EML 2023,Core,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
agents) excluding combinations,epinephrine,2% (as hydrochloride),WHO EML 2023,Complementary,21. OPHTHALMOLOGICAL PREPARATIONS,unit,20
agents) excluding combinations,Injection,25 mg/mL,WHO EML 2023,Complementary,21. OPHTHALMOLOGICAL PREPARATIONS,vial,20
agents) excluding combinations,Tablet,30 micrograms + 150 micrograms,WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,strip,20
agents) excluding combinations,Tablet,35 micrograms + 1 mg,WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,strip,20
agents) excluding combinations,Tablet,30 micrograms,WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,strip,20
agents) excluding combinations,Tablet,750 micrograms (pack of two),WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,strip,20
agents) excluding combinations,Tablet,1.5 mg,WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,strip,20
agents) excluding combinations,Tablet,30 mg (as acetate),WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,strip,20
estradiol cypionate + medroxyprogesterone,Injection,5 mg + 25 mg,WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,vial,20
acetate,Injection,150 mg mL in 1 mL vial,WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,vial,20
medroxyprogesterone acetate,Injection,104 mg/0.65 mL in pre-filled syringe or,WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,vial,20
medroxyprogesterone acetate,norethisterone,200 mg/mL in 1 mL ampoule,WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
copper-containing device,Intrauterine,with reservoir containing 52 mg of,WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
diaphragms,Single-rod,containing 68 mg of,WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
etonogestrel-releasing implant,Two-rod,each rod containing,WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
levonorgestrel-releasing implant,ethinylestradiol,containing 2.7 mg + 11.7 mg,WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
levonorgestrel-releasing implant,Progesterone-releasing,containing 2.074 g of,WHO EML 2023,Core,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
levonorgestrel-releasing implant,Tablet,50 mg (citrate),WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,strip,20
levonorgestrel-releasing implant,Therapeutic,Solid oral dosage form: 2.5 mg,WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
levonorgestrel-releasing implant,carbetocin,100 micrograms/mL,WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
levonorgestrel-releasing implant,Therapeutic,Injection: 200 micrograms (hydrogen maleate) in 1 mL ampoule,WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
levonorgestrel-releasing implant,Tablet,200 micrograms,WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,strip,20
misoprostol,Vaginal tablet,25 micrograms.*,WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,strip,20
misoprostol,Injection,10 IU in 1 mL,WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,vial,20
misoprostol,nifedipine,10 mg,WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
misoprostol,Injection,4 mg/mL (as disodium phosphate salt) in 1 mL ampoule,WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,vial,20
equivalent (400 micrograms),Injection,100 mg/mL in 10 mL ampoule,WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,vial,20
equivalent (400 micrograms),Injection,20 mg/mL (equivalent to 10 mg caffeine base/mL),WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,vial,20
equivalent (400 micrograms),Oral liquid,20 mg/mL (equivalent to 10 mg caffeine base/mL),WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,bottle,20
equivalent (400 micrograms),Solution,7.1% (digluconate) delivering 4% chlorhexidine (for,WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
equivalent (400 micrograms),Therapeutic,Solution for injection: 5 mg/mL,WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
equivalent (400 micrograms),Therapeutic,Solution for injection: 0.5 mg/mL in alcohol,WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
equivalent (400 micrograms),surfactant,25 mg/mL or 80 mg/mL,WHO EML 2023,Complementary,22. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE,unit,20
equivalent (400 micrograms),intraperitoneal,of appropriate composition,WHO EML 2023,Complementary,23. PERITONEAL DIALYSIS SOLUTION,unit,20
equivalent (400 micrograms),Injection,25 mg (decanoate or enantate) in 1 mL ampoule,WHO EML 2023,Core,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,vial,20
equivalent (400 micrograms),Therapeutic,Tablet: 2 mg,WHO EML 2023,Core,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
equivalent (400 micrograms),Therapeutic,5 mg,WHO EML 2023,Core,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
equivalent (400 micrograms),Injection,5 mg/mL in 1 mL ampoule,WHO EML 2023,Core,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,vial,20
equivalent (400 micrograms),olanzapine,10 mg in vial,WHO EML 2023,Core,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
equivalent (400 micrograms),Injection,25 mg,WHO EML 2023,Core,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,vial,20
equivalent (400 micrograms),Injection,50 mg,WHO EML 2023,Core,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,vial,20
equivalent (400 micrograms),Injection,75 mg,WHO EML 2023,Core,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,vial,20
equivalent (400 micrograms),Injection,100 mg,WHO EML 2023,Core,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,vial,20
equivalent (400 micrograms),clozapine,25 to 200 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
equivalent (400 micrograms),Tablet,25 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
equivalent (400 micrograms),Tablet,75mg (hydrochloride),WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
equivalent (400 micrograms),Solid,20 mg (as hydrochloride),WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
equivalent (400 micrograms),carbamazepine,100 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
equivalent (400 micrograms),carbamazepine,200 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
equivalent (400 micrograms),carbamazepine,400 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
equivalent (400 micrograms),lithium,300 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
equivalent (400 micrograms),Tablet,100 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
equivalent (400 micrograms),Tablet,150 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
equivalent (400 micrograms),Tablet,200 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
equivalent (400 micrograms),Therapeutic,300 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
equivalent (400 micrograms),Tablet,50 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
equivalent (400 micrograms),Tablet,300 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
equivalent (400 micrograms),bearing,200 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
equivalent (400 micrograms),bearing,500 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
birth defects and developmental disorders in children,Tablet,2 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
birth defects and developmental disorders in children,Tablet,5 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
anxiety symptoms only,Solid,20 mg (as hydrochloride),WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
anxiety symptoms only,Capsule,10 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
anxiety symptoms only,Capsule,25 mg (hydrochloride),WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
anxiety symptoms only,Tablet,333 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
anxiety symptoms only,Injection,380 mg in vial,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,vial,20
naltrexone,Tablet,50 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
naltrexone,bupropion,150 mg (hydrochloride),WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
naltrexone,Chewing,2 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
naltrexone,Chewing,4 mg (as polacrilex),WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
naltrexone,Lozenge,2 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
naltrexone,Lozenge,4 mg,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
naltrexone,Oral,1 mg per actuation,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
naltrexone,Transdermal patch,5 mg to 30 mg/16 hrs,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
naltrexone,Transdermal patch,7 mg to 21 mg/24 hrs,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
naltrexone,Tablet,"0.5 mg, 1 mg",WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,strip,20
naltrexone,Concentrate,5 mg/mL,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
naltrexone,Concentrate,10 mg/mL (hydrochloride),WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,unit,20
naltrexone,Oral liquid,5 mg/5 mL,WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,bottle,20
naltrexone,Oral liquid,10 mg/5 mL (hydrochloride),WHO EML 2023,Complementary,24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS,bottle,20
naltrexone,Injection,1 mg/mL (as hydrochloride or hydrogen tartrate) in,WHO EML 2023,Core,25. MEDICINES ACTING ON THE RESPIRATORY TRACT,vial,20
epinephrine (adrenaline),ipratropium,20 micrograms/metered dose,WHO EML 2023,Core,25. MEDICINES ACTING ON THE RESPIRATORY TRACT,unit,20
epinephrine (adrenaline),Inhalation,100 micrograms (as sulfate) per dose,WHO EML 2023,Core,25. MEDICINES ACTING ON THE RESPIRATORY TRACT,unit,20
epinephrine (adrenaline),Injection,50 micrograms/mL (as sulfate) in 5 mL ampoule,WHO EML 2023,Core,25. MEDICINES ACTING ON THE RESPIRATORY TRACT,vial,20
epinephrine (adrenaline),Metered,100 micrograms (as sulfate) per,WHO EML 2023,Core,25. MEDICINES ACTING ON THE RESPIRATORY TRACT,unit,20
epinephrine (adrenaline),Respirator,5 mg/mL (as sulfate),WHO EML 2023,Core,25. MEDICINES ACTING ON THE RESPIRATORY TRACT,unit,20
epinephrine (adrenaline),Therapeutic,"Powder for inhalaton, capsule: 18 micrograms",WHO EML 2023,Core,25. MEDICINES ACTING ON THE RESPIRATORY TRACT,unit,20
epinephrine (adrenaline),Injectable,5% (isotonic),WHO EML 2023,Core,"26. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID–BASE DISTURBANCES",unit,20
epinephrine (adrenaline),Injectable,10% (hypertonic),WHO EML 2023,Core,"26. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID–BASE DISTURBANCES",unit,20
glucose,Injectable,"4% glucose, 0.18% sodium chloride",WHO EML 2023,Core,"26. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID–BASE DISTURBANCES",unit,20
glucose,glucose,"5% glucose, 0.9% sodium chloride (equivalent",WHO EML 2023,Core,"26. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID–BASE DISTURBANCES",unit,20
glucose,Solution,11.2% in 20 mL ampoule,WHO EML 2023,Core,"26. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID–BASE DISTURBANCES",unit,20
potassium chloride,Solution,7.5% (equivalent to K 1 mmol/mL and Cl,WHO EML 2023,Core,"26. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID–BASE DISTURBANCES",unit,20
potassium chloride,Injectable,"0.9% isotonic (equivalent to Na+ 154 mmol/L,",WHO EML 2023,Core,"26. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID–BASE DISTURBANCES",unit,20
sodium chloride,Injectable,"1.4% isotonic (equivalent to Na+ 167 mmol/L,",WHO EML 2023,Core,"26. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID–BASE DISTURBANCES",unit,20
sodium hydrogen carbonate,Solution,8.4% in 10 mL ampoule (equivalent to Na+,WHO EML 2023,Core,"26. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID–BASE DISTURBANCES",unit,20
sodium hydrogen carbonate,Tablet,50 mg,WHO EML 2023,Core,27. VITAMINS AND MINERALS,strip,20
sodium hydrogen carbonate,Tablet,500 mg (elemental),WHO EML 2023,Core,27. VITAMINS AND MINERALS,strip,20
sodium hydrogen carbonate,Oral liquid,400 IU/mL,WHO EML 2023,Core,27. VITAMINS AND MINERALS,bottle,20
sodium hydrogen carbonate,Solid,400 IU,WHO EML 2023,Core,27. VITAMINS AND MINERALS,unit,20
sodium hydrogen carbonate,Solid,1000 IU,WHO EML 2023,Core,27. VITAMINS AND MINERALS,unit,20
sodium hydrogen carbonate,Oral liquid,250 micrograms/mL (10 000 IU/mL),WHO EML 2023,Core,27. VITAMINS AND MINERALS,bottle,20
sodium hydrogen carbonate,Solid,1.25 mg (50 000 IU),WHO EML 2023,Core,27. VITAMINS AND MINERALS,unit,20
sodium hydrogen carbonate,Capsule,190 mg,WHO EML 2023,Core,27. VITAMINS AND MINERALS,strip,20
sodium hydrogen carbonate,Iodized,1 mL (480 mg iodine),WHO EML 2023,Core,27. VITAMINS AND MINERALS,unit,20
sodium hydrogen carbonate,Iodized,0.5 mL (240 mg iodine) in,WHO EML 2023,Core,27. VITAMINS AND MINERALS,unit,20
values,Tablet,50 mg,WHO EML 2023,Core,27. VITAMINS AND MINERALS,strip,20
values,Tablet,25 mg (hydrochloride),WHO EML 2023,Core,27. VITAMINS AND MINERALS,strip,20
values,Capsule,50 000 IU,WHO EML 2023,Core,27. VITAMINS AND MINERALS,strip,20
values,Capsule,100 000 IU,WHO EML 2023,Core,27. VITAMINS AND MINERALS,strip,20
values,Capsule,200 000 IU (as palmitate),WHO EML 2023,Core,27. VITAMINS AND MINERALS,strip,20
values,Oral,100 000 IU/mL (as palmitate) in multidose,WHO EML 2023,Core,27. VITAMINS AND MINERALS,unit,20
retinol,Tablet,10 000 IU (as palmitate),WHO EML 2023,Core,27. VITAMINS AND MINERALS,strip,20
retinol,Water-miscible,100 000 IU (as palmitate) in,WHO EML 2023,Core,27. VITAMINS AND MINERALS,unit,20
retinol,Tablet,5 mg,WHO EML 2023,Core,27. VITAMINS AND MINERALS,strip,20
retinol,Tablet,50 mg (hydrochloride),WHO EML 2023,Core,27. VITAMINS AND MINERALS,strip,20
retinol,Injection,100 mg/mL in 10 mL ampoule,WHO EML 2023,Complementary,27. VITAMINS AND MINERALS,vial,20
retinol,acetic,"2%, in alcohol",WHO EML 2023,Core,"28. EAR, NOSE AND THROAT MEDICINES",unit,20
retinol,Nasal,100 micrograms per dose,WHO EML 2023,Core,"28. EAR, NOSE AND THROAT MEDICINES",unit,20
retinol,Solution,0.3% (as hydrochloride),WHO EML 2023,Core,"28. EAR, NOSE AND THROAT MEDICINES",unit,20
retinol,Tablet,100 mg,WHO EML 2023,Core,29. MEDICINES FOR DISEASES OF JOINTS,strip,20
retinol,Tablet,150 mg (as phosphate or sulfate),WHO EML 2023,Core,29. MEDICINES FOR DISEASES OF JOINTS,strip,20
retinol,Tablet,50 mg,WHO EML 2023,Complementary,29. MEDICINES FOR DISEASES OF JOINTS,strip,20
retinol,hydroxychloroquine,200 mg (as sulfate),WHO EML 2023,Complementary,29. MEDICINES FOR DISEASES OF JOINTS,unit,20
retinol,Tablet,2.5 mg (as sodium),WHO EML 2023,Complementary,29. MEDICINES FOR DISEASES OF JOINTS,strip,20
retinol,penicillamine,250 mg,WHO EML 2023,Complementary,29. MEDICINES FOR DISEASES OF JOINTS,unit,20
retinol,Tablet,500 mg,WHO EML 2023,Complementary,29. MEDICINES FOR DISEASES OF JOINTS,strip,20
retinol,Suppository,50 mg to 150 mg,WHO EML 2023,Complementary,29. MEDICINES FOR DISEASES OF JOINTS,unit,20
retinol,Tablet,100 mg to 500 mg,WHO EML 2023,Complementary,29. MEDICINES FOR DISEASES OF JOINTS,strip,20
retinol,Therapeutic,Injection: 20 mg/mL in vial,WHO EML 2023,Complementary,29. MEDICINES FOR DISEASES OF JOINTS,unit,20
retinol,Gel,containing 2500 to 12 500 ppm fluoride (any type),WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
retinol,Mouthrinse,containing 230 to 900 ppm fluoride (any type),WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
fluoride,"Toothpaste,",containing 1000 to 1500 ppm fluoride,WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
fluoride,Varnish,containing 22 500 ppm fluoride (any type),WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
fluoride,Single-use,0.4 g powder + 0.09 mL liquid,WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
fluoride,Multi-use,powder + liquid,WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
fluoride,glass,"25-50% silicate, 20-40%",WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
fluoride,quantities.,"7-25% polybasic carboxylic acid,",WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
fluoride,silver,38% w/v,WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
fluoride,Table,Medicines with age or weight restrictions,WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
fluoride,Table,Explanation of dosage forms,WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
fluoride,in,gastro-,WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
fluoride,Topical,"lotions, paints",WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
fluoride,For,"cream, ointment",WHO EML 2023,Core,30. DENTAL MEDICINES AND PREPARATIONS,unit,20
